1. Alkermes' major I-O hope sees progress in early cancer tests — Under pressure, Pfizer and others join Moderna in publishing COVID vaccine trial protocols — Survey finds nearly half of Americans would not get a COVID vaccine if it were available today — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Enbrel ex-McKinsey nerd

Discussion in 'Amgen' started by anonymous, Aug 2, 2017 at 1:09 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    how will this man save Enbrel? Or is he just another suit vying for a promotion.
     

  2. anonymous

    anonymous Guest

    who ever has the better spreadsheet wins.
     
  3. anonymous

    anonymous Guest

    What a fucking cry baby! Wah wah the sales force thinks I am
    a douche!
     
  4. anonymous

    anonymous Guest

    powerpoint slides and excel models will bring Enbrel to the promised land
     
  5. anonymous

    anonymous Guest

     
  6. anonymous

    anonymous Guest

    Watch it. He will be on the Laura Brand track and will be Vice President of sales with no sales or leadership experience except McKinsey. He will have no respect for any of us and will reduce your compensation to that of a janitor because you are not an MIT alum like him.
     
  7. anonymous

    anonymous Guest

    Bet he's a sociopath who only cares for himself and his career like any one at amgen now who is a level 7 or above
     
  8. anonymous

    anonymous Guest

    Soon China will take over the world and force everyone to be communist and eat dogs
     
  9. anonymous

    anonymous Guest

    Just do a 2X2 assessment and you can solve any issue - even Enbrel. The fact that it is a 20 year old product, lacks the efficacy in PsO, has no reimbursement parity and has been over priced for the last 6 years. Simple...stupid is as stupid does.
     
  10. anonymous

    anonymous Guest

    Enbrel won't get parity coverage, but will still bleed sales just to be covered at all. Congratulate the reimbursement folks when you see them.

    They're killing future value of the biosimilar market with the deep discounts that will be expected copycats. Someone from the biosimilar brand team should be screaming murder before launch.
     
  11. anonymous

    anonymous Guest

    Sounds like global politics being acted out in Los Angeles. New Jersey isn't this entertaining.
     
  12. anonymous

    anonymous Guest

    JC will only promote the right people after these hateful posts. I know who get lay offs first!
     
  13. anonymous

    anonymous Guest

    He doesn't need marketing experience because he knows
    Strategy, worked McKinsey and has an MIT degree. Don't you know that means he is better than everyone else. Reps who went to state schools are like retarded and have no value in his eyes. The only schools worth going to him are ivied and equivalents. The rest of the educational system means you are worthless, waste of precious earth resources and don't deserve to live.
     
  14. anonymous

    anonymous Guest

    Jay's model shows higher net value to Amgen by laying off half the sales force with minimal disruption. Increase in McKinsey service also has high value. This man is no friend to the field.
     
  15. anonymous

    anonymous Guest

    The red army has infiltrated Amgen
     
  16. anonymous

    anonymous Guest

    Amgen making more money now in Asia. I got Amgen into big market and fire all you losers.
     
  17. anonymous

    anonymous Guest


    Jay will help amgen increase sales in China with backside deals with the communist. This will give him leverage to reduce the field force who does nothing but bring coffee and no selling. One backdoor anal deals gets you another and JC knows his stinker holes from extensive experience.
     
  18. anonymous

    anonymous Guest

    Nerd boy is gonna lead the INBU to glory. Just wait, his power point slides will have embedded dragons to kill Humira reps so all business goes to us. The power of MIT nerds past and present is strong in him.
     
  19. anonymous

    anonymous Guest

    He's bound to fail, but we need him for increased sales in JAPAC down the line. He owns us.
     
  20. anonymous

    anonymous Guest

    You sure it isn't the other way around? It seems like they need him